stoxline Quote Chart Rank Option Currency Glossary
  
CVS Health Corp. (CVS)
107.61  0.14 (0.13%)    07-20 16:00
Open: 107.31
High: 108.88
Volume: 4,600,908
  
Pre. Close: 107.47
Low: 107.14
Market Cap: 137,303(M)
Technical analysis
2026-07-20 4:43:24 PM
Short term     
Mid term     
Targets 6-month :  127.26 1-year :  148.64
Resists First :  108.95 Second :  127.26
Pivot price 104.93
Supports First :  102.08 Second :  97.83
MAs MA(5) :  106.73 MA(20) :  104.38
MA(100) :  87.57 MA(250) :  79.51
MACD MACD :  2.6 Signal :  2.6
%K %D K(14,3) :  76.3 D(3) :  76.2
RSI RSI(14): 68.5
52-week High :  108.95 Low :  57.05
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ CVS ] has closed below upper band by 7.5%. Bollinger Bands are 42.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 109.01 - 109.43 109.43 - 109.85
Low: 106.03 - 106.53 106.53 - 107.04
Close: 106.81 - 107.58 107.58 - 108.35
Company Description

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Headline News

Mon, 20 Jul 2026
Dividend Investors: Don't Be Too Quick To Buy CVS Health Corporation (NYSE:CVS) For Its Upcoming Dividend - simplywall.st

Mon, 20 Jul 2026
CVS Health Update: The C- Student Now Pulling Down A B+ (NYSE:CVS) - Seeking Alpha

Mon, 20 Jul 2026
Jennison Associates LLC Lowers Stake in CVS Health Corporation $CVS - MarketBeat

Sun, 19 Jul 2026
SEB Asset Management AB Takes $62.64 Million Position in CVS Health Corporation $CVS - MarketBeat

Sun, 19 Jul 2026
CVS Health Corporation $CVS Shares Acquired by AIA Group Ltd - MarketBeat

Fri, 17 Jul 2026
CVS Pharmacy® celebrates opening of first pharmacy-focused location in Houston - CVS Health

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Healthcare Plans
Shares Out 1,280 (M)
Shares Float 1,270 (M)
Held by Insiders 0 (%)
Held by Institutions 90.3 (%)
Shares Short 19,940 (K)
Shares Short P.Month 17,760 (K)
Stock Financials
EPS 2.27
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 60.84
Profit Margin 0.7 %
Operating Margin 4.1 %
Return on Assets (ttm) 2.6 %
Return on Equity (ttm) 3.7 %
Qtrly Rev. Growth 6 %
Gross Profit (p.s.) 42.42
Sales Per Share 316.89
EBITDA (p.s.) 12.03
Qtrly Earnings Growth 63 %
Operating Cash Flow 10,330 (M)
Levered Free Cash Flow 5,200 (M)
Stock Valuations
PE Ratio 47.2
PEG Ratio 0.2
Price to Book value 1.76
Price to Sales 0.33
Price to Cash Flow 13.33
Stock Dividends
Dividend 0.67
Forward Dividend 0
Dividend Yield 0.6%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android